COHANCE LIFESCIENCES LTD

Overview

COHANCE LIFESCIENCES LTD is an active pharmaceutical ingredient (API) supplier with 63 active FDA Type II Drug Master Files, covering (S)-8-ETHYL-8-HYDROXY-2,3,5,8-TETRAHYDRO-6-OXA-3A-AZA-CYCLOPENTA[B]NAPHTHALENE-1,4,7-TRIONE (400012); 1-ACETAMIDO 3,5-DIMETHYL ADAMANTANE; 7-ETHYL-10-HYDROXYCAMPTOTHECIN; APIXABAN; ARIPIPRAZOLE USP; ATOMOXETINE HYDROCHLORIDE USP.

API / Drug Master Files

COHANCE LIFESCIENCES LTD holds 62 active (62 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PYRIDOSTIGMINE BROMIDE USPActive2026-03-18
• IRINOTECAN HYDROCHLORIDE TRIHYDRATEActive2026-03-05
• EXATECAN MESYLATEActive2026-01-23
• CILOSTAZOLActive2025-12-03
• HYDROXYZINE PAMOATE USPActive2025-11-04
• LISDEXAETAMINEActive2025-07-11
• BUSPIRONE HYDROCHLORIDE USPActive2025-01-22
• DESVENLAFAXINE SUCCINATEActive2024-11-20
• OLIVETOLActive2024-09-27
• 7-ETHYL-10-HYDROXYCAMPTOTHECINActive2024-09-09
• (S)-8-ETHYL-8-HYDROXY-2,3,5,8-TETRAHYDRO-6-OXA-3A-AZA-CYCLOPENTA[B]NAPHTHALENE-1,4,7-TRIONE (400012)Active2023-10-20
• EMPAGLIFLOZINActive2022-07-12
• MARAVIROCActive2021-09-24
• PROBENECID USPActive2021-08-04
• PIRIBEDILActive2020-11-24

Showing 15 of 62 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to COHANCE LIFESCIENCES LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.